Clinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy

Sadeleştirilmiş öğe sayfası
dc.contributor.authorMustafayev, Teuta Zoto
dc.contributor.authorTurna, Menekse
dc.contributor.authorBolukbasi, Yasemin
dc.contributor.authorTezcanli, Evrim
dc.contributor.authorGuney, Yildiz
dc.contributor.authorDincbas, Fazilet Oner
dc.contributor.authorAtasoy, Beste Melek
dc.contributor.authorUgurluer, Gamze
dc.contributor.authorCaglar, Hale Basak
dc.contributor.authorAtalar, Banu
dc.contributor.authorOzyar, Enis
dc.date.accessioned2025-10-16T15:12:54Z
dc.date.issued2024
dc.identifier.doi10.1186/s12885-024-12643-6
dc.identifier.otherWOS:001281076100004
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/5664
dc.publisherBMC
dc.sourceBMC CANCER
dc.subjectRadiation induced toxicity
dc.subjectBrain metastasis
dc.subjectStereotactic radiosurgery
dc.subjectBevacizumab
dc.titleClinical and radiological effects of Bevacizumab for the treatment of radionecrosis after stereotactic brain radiotherapy
dc.typeArticle

Dosyalar

Koleksiyonlar

WOS